$ROIV insider trading

Over the last 12 months, Roivant Sciences insiders reported no purchases and 9 sales totaling $203.8M across SEC Form 4 filings. 44% of the activity was filed under pre-arranged 10b5-1 trading plans.

$203.8M
9
7
44%
Side
$100K$1.0M$10M$100MJun '26JulAug
Venker Eric
MANCHESTER KEITH S
Fitzgerald Meghan
Epperly Melissa B,
Sukhatme Mayukh

All insider trades

Jul 27, 2026Venker Eric▼ Sale200,000$34.95$7.0M-11%
Jun 30, 2026Fitzgerald Meghan▼ Sale10,000$34.9$349K-18.9%
Jun 30, 2026MANCHESTER KEITH S▼ Sale200,000$35.45$7.1M-10.3%
Jun 30, 2026MANCHESTER KEITH S▼ Sale1,438,163$34.32$49.4M-9.5%
Jun 30, 2026Gold Daniel Allen▼ Sale1,438,163$34.32$49.4M-9.5%
Jun 30, 2026QVT Financial LP▼ Sale1,438,163$34.32$49.4M-9.5%
Jun 29, 2026Epperly Melissa B,▼ Sale17,750$34.38$610K-51.9%
Jun 26, 2026Sukhatme Mayukh▼ Sale1,000,000$34.1$34.1M-5.1%
Jun 24, 2026Venker Eric▼ Sale200,000$33.16$6.6M-11%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ROIV feed.

ROIV Insider Trading — Form 4 Buys & Sells | alphai